Invention Application
- Patent Title: DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
-
Application No.: US18820609Application Date: 2024-08-30
-
Publication No.: US20250090666A1Publication Date: 2025-03-20
- Inventor: Antonin DE FOUGEROLLES , Sayda M. ELBASHIR
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTX, Inc.
- Current Assignee: ModernaTX, Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: A61K47/18
- IPC: A61K47/18 ; A61K31/7088 ; A61K31/7115 ; A61K38/19 ; A61K38/48 ; A61K47/22 ; A61K47/28 ; A61K48/00 ; C07K14/535 ; C12N9/64 ; C12N15/67 ; C12N15/87
Abstract:
Provided are formulations, compositions and methods for delivering biological moieties such as modified nucleic acids into cells to modulate protein expression. Such compositions and methods include the delivery of biological moieties, and are useful for production of proteins.
Information query
IPC分类:
